I appreciate the dismay of the past, but I would suggest a new company has arrived. Their ownership and revenue from Northern vine will quickly generate large and quickly growing revenues, given the paucity of needed lab services.
FWIW Goldman Sachs follows ATBF and has a Buy on it
I don't care for the hype that exploded in our faces from 2014 onward either, but the company could actually accomplish something now. We agree on the past, but disagree on the future.